Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Neuroscience

• Publication date

  2002-06-12

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0306-4522(02)00056-8PMID 12044473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of four staining methods on the detection of neuritic plaques

  2004cited by this paper
• Subtypes and differential laminar distributions of βA4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases

  2004cited by this paper
• A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated byβ protein immunostaining

  2004cited by this paper
• The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.

  2001cited by this paper
• Advanced use of 3-D methods for counting neurons

  2001cited by this paper
• The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer’s disease

  2001cited by this paper
• Growth Arrest of Individual Senile Plaques in a Model of Alzheimer's Disease Observed by In Vivo Multiphoton Microscopy

  2001cited by this paper
• Sequence of Abeta-protein deposition in the human medial temporal lobe.

  2000cited by this paper
• Abeta-generating enzymes: recent advances in beta- and gamma-secretase research.

  2000cited by this paper
• Microglia, amyloid and dementia in alzheimer disease. A correlative study.

  2000cited by this paper
• Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.

  2000cited by this paper
• Laminar specific loss of isocortical presenilin 1 immunoreactivity in Alzheimer's disease. Correlations with the amyloid load and the density of tau‐positive neurofibrillary tangles

  2000cited by this paper
• Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice

  2000cited by this paper
• Sequence of Aβ‐Protein Deposition in the Human Medial Temporal Lobe

  2000cited by this paper
• Practical approaches to stereology in the setting of aging- and disease-related brain banks.

  2000cited by this paper
• Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment.

  1999cited by this paper
• Microtechnology: Laying it on thick

  1999cited by this paper
• Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

  1999cited by this paper
• Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of Abeta.

  1999cited by this paper
• Entorhinal Cortex β-Amyloid Load in Individuals with Mild Cognitive Impairment

  1999cited by this paper
• Translating cell biology into therapeutic advances in Alzheimer's disease

  1999cited by this paper
• The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging.

  1999cited by this paper
• Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

  1998cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

  1997cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

  1997cited by this paper
• Modeling the relation between neurofibrillary tangles and intellectual status.

  1997cited by this paper
• Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.

  1996cited by this paper
• β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease

  1996cited by this paper
• Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques.

  1996cited by this paper
• Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

  1995cited by this paper
• Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

  1995cited by this paper
• Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.

  1995cited by this paper
• Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain

  1995cited by this paper
• Candidate gene for the chromosome 1 familial Alzheimer's disease locus

  1995cited by this paper
• Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)

  1994cited by this paper
• Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

  1994cited by this paper
• Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older.

  1993cited by this paper
• Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes.

  1993cited by this paper
• Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques.

  1992cited by this paper
• Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

  1992cited by this paper
• Distribution of Alzheimer‐type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease

  1992cited by this paper
• The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.

  1991cited by this paper
• Diffuse type of senile plaques in the brains of Alzheimer-type dementia

  1988cited by this paper
• The efficiency of systematic sampling in stereology and its prediction *

  1987cited by this paper
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

  1984cited by this paper
• A New Clinical Scale for the Staging of Dementia

  1982cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• KBN2202, a Salicylic Acid Derivative, Preserves Neuronal Architecture, Enhances Neurogenesis, Attenuates Amyloid and Inflammatory Pathology, and Restores Recognition Memory in 5xFAD Mice at an Advanced Stage of AD Pathophysiology

  2025cites this paper
• Tracking a decade of structural changes in preclinical and prodromal Alzheimer’s disease: insights from amyloid-β pathology

  2025cites this paper
• Endogenously generated Dutch-type Aβ nonfibrillar aggregates dysregulate presynaptic neurotransmission in the absence of detectable inflammation

  2025cites this paper
• Brain volume change following anti-amyloid β immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophy.

  2024cites this paper
• Application of the Japanese Verbal Learning Test to Patients With Alzheimer’s Disease in the Early Stage

  2024cites this paper
• Mammalian Models in Alzheimer’s Research: An Update

  2023cites this paper
• Evidence of traumatic brain injury in headbutting bovids

  2022cites this paper
• Brain alterations in the early Alzheimer’s continuum with amyloid-β, tau, glial and neurodegeneration CSF markers

  2022cites this paper
• Comparative neuropathology in aging primates: A perspective

  2021cites this paper
• Wolframin-1–expressing neurons in the entorhinal cortex propagate tau to CA1 neurons and impair hippocampal memory in mice

  2021cites this paper
• Medial temporal lobe volume is associated with neuronal loss but not with hippocampal microinfarcts despite their high frequency in aging brains.

  2020cites this paper
• The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease

  2020cites this paper
• Associations of [18F]-APN-1607 Tau PET Binding in the Brain of Alzheimer’s Disease Patients With Cognition and Glucose Metabolism

  2020cites this paper
• Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease.

  2019cites this paper
• Evolutionary shifts dramatically reorganized the human hippocampal complex

  2019cites this paper
• Cognitive impairment after traumatic brain injury is associated with reduced long-term depression of excitatory postsynaptic potential in the rat hippocampal dentate gyrus

  2018cites this paper
• Early Alzheimer-type lesions in cognitively normal subjects.

  2018cites this paper
• What Can Be and What Cannot Be Accomplished With PET: Rectifying Ongoing Misconceptions

  2017cites this paper
• A Study of Aβ Oligomers in the Temporal Cortex and Cerebellum of Patients with Neuropathologically Confirmed Alzheimer's Disease Compared to Aged Controls

  2016cites this paper
• Hippocampal Aβ expression, but not phosphorylated tau, predicts cognitive deficits following repeated peripheral poly I:C administration.

  2016cites this paper
• Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment

  2015cites this paper
• Neuroanatomical Correlates of Recognizing Face Expressions in Mild Stages of Alzheimer’s Disease

  2015cites this paper
• Astrocyte physiopathology: At the crossroads of intercellular networking, inflammation and cell death.

  2015cites this paper
• BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease.

  2014cites this paper
• TDP-43 Pathology in the Population: Prevalence and Associations with Dementia and Age

  2014cites this paper
• Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology

  2014cites this paper
• Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.

  2014cites this paper
• The effect of PN-1, a Traditional Chinese Prescription, on the Learning and Memory in a Transgenic Mouse Model of Alzheimer's Disease

  2013cites this paper
• Astrocyte signaling and neurodegeneration

  2013cites this paper
• The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy

  2013cites this paper
• Cerebral Microvascular Rather than Parenchymal Amyloid-β Protein Pathology Promotes Early Cognitive Impairment in Transgenic Mice

  2013cites this paper
• Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

  2012cites this paper
• Cognition, glucose metabolism and amyloid burden in Alzheimer's disease.

  2012influential citation
• Preclinical PET as Translational Tool for Imaging Alzheimer's Disease

  2012cites this paper
• Amyloid-β imaging with PET in Alzheimer’s disease: is it feasible with current radiotracers and technologies?

  2012cites this paper
• The neuropathological profile of mild cognitive impairment (MCI): a systematic review

  2012cites this paper
• Correlating Neuropsychiatric Symptoms with Regional Beta-Amyloid Load in the Alzheimer’s Disease Brain Using [11C]SB-13 Positron Emission Tomography

  2011influential citation
• Centenarian Studies: Important Contributors to Our Understanding of the Aging Process and Longevity

  2011cites this paper
• The Geneva brain collection

  2011cites this paper
• Implications of Gliotransmission for the Pharmacotherapy of CNS Disorders

  2011cites this paper
• BACE: A (Almost) Perfect Target for Staving off Alzheimer's Disease

  2011cites this paper
• Astrocyte-Neuron Communication: What Goes Wrong in Pathology?

  2011cites this paper
• Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid β‐peptide

  2011cites this paper
• Small Vascular and Alzheimer Disease-Related Pathologic Determinants of Dementia in the Oldest-Old

  2010cites this paper
• Changes in dendritic complexity and spine morphology in transgenic mice expressing human wild-type tau

  2010cites this paper
• Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD.

  2010cites this paper
• Neuropathological analysis of lacunes and microvascular lesions in late‐onset depression

  2010cites this paper
• Brain Aging in the Oldest-Old

  2010cites this paper
• Neocortical Variation of Aβ Load in Fully Expressed, Pure Alzheimer's Disease

  2010cites this paper
• Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.

  2009cites this paper
• Multi-parametric classification of Alzheimer's disease and mild cognitive impairment: The impact of quantitative magnetization transfer MR imaging

  2009cites this paper
• Differential Impact of Lacunes and Microvascular Lesions on Poststroke Depression

  2009cites this paper
• Classification and basic pathology of Alzheimer disease

  2009cites this paper
• In vivo mapping of amyloid toxicity in Alzheimer disease

  2009cites this paper
• Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.

  2009cites this paper
• strocytic dysfunction : Insights on the role in neurodegeneration

  2009cites this paper
• Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein

  2008cites this paper
• Differential Changes in Synaptic Proteins in the Alzheimer Frontal Cortex with Marked Increase in PSD-95 Postsynaptic Protein

  2008cites this paper
• Behavior of neural stem cells in the Alzheimer brain

  2008cites this paper
• β‐amyloid burden is not associated with rates of brain atrophy

  2008cites this paper
• Le cerveau aux limites du vieillissement: à propos des nonagénaires et centenaires

  2008cites this paper
• Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: relationship with the progression of Alzheimer's disease.

  2008cites this paper
• Identification of Alzheimer and vascular lesion thresholds for mixed dementia.

  2007cites this paper
• Validation of clinical criteria for possible vascular dementia in the oldest-old.

  2007cites this paper
• Anti-dementia drugs and hippocampal-dependent memory in rodents

  2007cites this paper
• Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia

  2007cites this paper
• Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

  2007cites this paper
• Stereological analysis of neuropil threads in the hippocampal formation: relationships with Alzheimer's disease neuronal pathology and cognition

  2007cites this paper
• Pathological correlates of cognitive decline in Alzheimer's disease.

  2007cites this paper
• Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm?

  2007cites this paper
• MRI-based measures in Alzheimer's disease and related disorders : regions of interest and automated techniques

  2007influential citation
• β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

  2007cites this paper
• b -amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer’s disease

  2007cites this paper
• Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia.

  2007cites this paper
• Moderate consumption of Cabernet Sauvignon attenuates A� neuropathology in a mouse model of Alzheimer's disease

  2006cites this paper
• Stereologic Analysis of Microvascular Morphology in the Elderly: Alzheimer Disease Pathology and Cognitive Status

  2006cites this paper
• The Canine Model of Human Brain Aging: Cognition, Behavior, and Neuropathology

  2006cites this paper
• A comparative assessment of γ-secretase activity in transgenic and non-transgenic rodent brain

  2006cites this paper
• A comparative assessment of gamma-secretase activity in transgenic and non-transgenic rodent brain.

  2006cites this paper
• Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience

  2006cites this paper
• Quantitative MR imaging in Alzheimer disease.

  2006cites this paper
• Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease.

  2006cites this paper
• Single cell gene expression profiling in Alzheimer’s disease

  2006cites this paper
• Models of Alzheimer's Disease

  2006cites this paper
• NMDA Receptor Activation Inhibits α-Secretase and Promotes Neuronal Amyloid-β Production

  2005influential citation
• Effects of adoptive transfer of beta-amyloid sensitive immune cells in a mouse model for Alzheimer's disease

  2005cites this paper
• Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease

  2005cites this paper
• NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production.

  2005cites this paper
• Stereologic analysis of hippocampal Alzheimer's disease pathology in the oldest-old: evidence for sparing of the entorhinal cortex and CA1 field.

  2005cites this paper
• NMDAReceptorActivationInhibits-Secretaseand PromotesNeuronalAmyloid-Production

  2005cites this paper
• Neurodegenerative Diseases: The neuropathology of Alzheimer's disease in the year 2005

  2005cites this paper
• Caloric restriction attenuates β‐amyloid neuropathology in a mouse model of Alzheimer's disease

  2005cites this paper
• Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.

  2005cites this paper
• Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer’s disease

  2005cites this paper
• Overexpression of the human β-amyloid precursor protein downregulates cortistatin mRNA in PDAPP mice

  2004cites this paper
• The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease

  2004cites this paper
• Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease

  2004cites this paper
• Frontal lobe volume, function, and beta-amyloid pathology in a canine model of aging.

  2004influential citation
• The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice.

  2004cites this paper
• Neuropathologic Correlates of Late-Onset Major Depression

  2004cites this paper